Restless legs syndrome (RLS) occurs commonly during pregnancy and can sometimes casues significant sleep disturbance. A new study suggests that RLS may also increase the risk of perinatal depression.
Maternal depression has been identified as a risk factor for adolescent depression. In addition, maternal depression appears to increase the risk of certain behavioral problems in children; however, it appears that the timing of exposure may play an important role in mediating the effects of maternal depression. A recent study suggests that childhood exposure to maternal depression between the ages of 4 and 14 may result in risky behaviors later on during adolescence.
In every cell, genetic material is contained within the double-stranded molecules of DNA called chromosomes. Every time a cell divides, the chromosomes are copied so that each new cell gets a copy of this genetic material. However, the process isn’t perfect – a little bit of the end of the chromosome is lost each time so the copy is not a perfect reproduction. To prevent important genetic material from being lost, the cell protects itself with structures called telomeres located at the ends of the chromosomes. Telomeres are repeating DNA sequences and proteins that act like a guard so that when the chromosome is copied, the important material is protected and only the telomere is shortened. Since telomere shortening happens every time the cell divides, telomeres act like biological clocks for the cell. When the chromosome has been copied enough times that the telomere has been completely worn away, any future copies of the chromosome may be missing important genetic material and the cell may cease to function normally.
We previously reported on studies suggesting estrogen may be helpful for the treatment of depression in peri- and post-menopausal women, either alone or in combination with an antidepressant. In addition, other studies have suggested that older, postmenopausal women may respond more poorly to antidepressants than premenopausal women. Two recent studies attempt to better understand the impact of reproductive hormones on clinical presentation and treatment response of depression in women.
A substantial proportion of women transitioning into menopause experience a new onset or recurrence of depressive symptoms. A new study from the Center for Women’s Mental Health indicates that duloxetine (Cymbalta) is effective for the treatment of depression and may also have a beneficial effect on vasomotor symptoms (hot flashes and night sweats).
Over the last decade, the number of reproductive-age women treated for depression has increased significantly. Given the incomplete information available regarding the reproductive safety of many antidepressant medications, many women choose to discontinue pharmacologic treatment during pregnancy. However, several studies estimate that about 10 to 15% of women suffer from depression during pregnancy (O'Hara et al, 1990; Evans et al, 2001). A recent study from the Center for Women's Mental Health indicates that the risk for depression is particularly high among women with histories of major depression (Cohen et al, 2006).
